TABLE 2—
Enrolled in Month of Diagnosis (n = 142) | Enrolled 1–11 Months Before Diagnosis (n = 210) | Enrolled in All 12 Months Before Diagnosis (n = 536) | |
SEER summary stage, no. (%a)* | |||
Localized | 41 (28.9) | 105 (50.0) | 291 (54.3) |
Regional | 62 (43.7) | 83 (39.5) | 181 (33.8) |
Distant/unknown | 39 (27.5) | 22 (10.5) | 64 (11.9) |
Stage at diagnosis, no. (%a)* | |||
Early | 41 (28.9) | 105 (50.0) | 291 (54.3) |
Late/unknown | 101 (71.1) | 105 (50.0) | 245 (45.7) |
Socioeconomic status quintile,b no. (%a) | |||
1 (lowest) | 57 (40.1) | 100 (47.6) | 267 (49.8) |
2 | 40 (28.2) | 46 (21.9) | 140 (26.1) |
3 | 22 (15.5) | 34 (16.2) | 76 (14.2) |
4 | 11 (7.8) | 17 (8.1) | 38 (7.1) |
5 (highest) | 12 (8.5) | 13 (6.2) | 15 (2.8) |
Race/ethnicity, no. (%a)* | |||
Non-Hispanic White | 48 (33.8) | 75 (35.7) | 184 (34.3) |
Non-Hispanic Black | 7 (4.9) | 23 (11.0) | 95 (17.7) |
Hispanic | 73 (51.4) | 90 (42.9) | 184 (34.3) |
Non-Hispanic Asian | 13 (9.2) | 12 (5.7) | 44 (8.2) |
Non-Hispanic Vietnamese | 1 (0.7) | 10 (4.8) | 29 (5.4) |
Age at diagnosis, mean ±SD | 46.1 ±9.5 | 41.7 ±9.7 | 41.5 ±10.4 |
Age at diagnosis, y, no. (%a)* | |||
15–29 | 3 (2.1) | 20 (9.5) | 63 (11.8) |
30–39 | 37 (26.1) | 70 (33.3) | 186 (34.7) |
40–49 | 51 (35.9) | 78 (37.1) | 168 (31.3) |
50–59 | 35 (24.7) | 33 (15.7) | 86 (16.0) |
60–64 | 16 (11.3) | 9 (4.3) | 33 (6.2) |
Marital status, no. (%a) | |||
Married | 55 (38.7) | 77 (36.7) | 168 (31.3) |
Not married | 87 (61.3) | 133 (63.3) | 368 (68.7) |
Histology, no. (%a) | |||
Squamous | 111 (78.2) | 163 (77.6) | 434 (81.0) |
Adenocarcinoma | 19 (13.4) | 28 (13.3) | 58 (10.8) |
Adenosquamous | 6 (4.2) | 8 (3.8) | 20 (3.7) |
Other | 6 (4.2) | 11 (5.2) | 24 (4.5) |
Note. SEER = Surveillance, Epidemiology, and End Results. As a result of rounding, percentages may not sum to 100.
aPercentage within Medicaid group.
bOn the basis of 2000 census block-group-level quintiles.
*P <.001.